FDA Adverse Event Injury Summary report: N

VOLUMAT MC AGILIA BR

MDR report key: 25340418 · Received May 29, 2026

Report

Report Number
3000240707-2026-00215
Event Type
Injury
Date Received
May 29, 2026
Date of Event
May 22, 2026
Report Date
May 29, 2026
Manufacturer
FRESENIUS VIAL S.A.S
Product Code
FRN
PMA / PMN Number
K121613
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
BR
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

N/A.

Description of Event or Problem · 0

THE FOLLOWING HAS BEEN REPORTED: PATIENT PRESENTED NAUSEA, HYPERSENSITIVITY REACTION, AND BLURRED VISION DURING THE INFUSION. AFTER THE ONSET OF THE ADVERSE REACTION, THE INFUSION WAS TEMPORARILY INTERRUPTED AND SUBSEQUENTLY RESUMED. THERE WERE ADDITIONAL PAUSES DURING THE INFUSION FOR BATHROOM BREAKS. MEDICATION: PACLITAXEL 160.8 MG START OF MEDICATION USE: (B)(6) 2026 13:10. INFUSION INTERRUPTION AFTER THE ONSET OF THE ADR: (B)(6) 2026 13:16. INFUSION RESUMED: (B)(6) 2026 14:15. END OF INFUSION: (B)(6) 2026 16:00 (BATHROOM BREAKS). REPORTING AS A CONSERVATIVE MEASURE. ADVERSE EVENT EFFECTS WERE REPORTED. ADDITIONAL INFORMATION IS NEEDED TO COMPLETE THE INVESTIGATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
391342 VOLUMAT MC AGILIA BR INFUSION PUMP SYSTEM FRN FRESENIUS VIAL S.A.S Z019140

Patients

Seq Age Sex Outcome Treatment
1